Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
TNYA

TNYA - Tenaya Therapeutics, Inc. Stock Price, Fair Value and News

$0.66-0.04 (-5.71%)
Market Closed

Price Targets

TNYA Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

TNYA Price Action

Last 7 days

-8.3%

Last 30 days

-8.3%

Last 90 days

-47.6%

Trailing 12 Months

-41.6%

TNYA RSI Chart

TNYA Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

TNYA Valuation

Market Cap

109.9M

Price/Earnings (Trailing)

-1.17

EV/EBITDA

-0.63

Price/Free Cashflow

-1.5

MarketCap/EBT

-1.17

TNYA Price/Earnings (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

TNYA Fundamentals

TNYA Earnings

Earnings (TTM)

-94.3M

Earnings Growth (Yr)

20.91%

Earnings Growth (Qtr)

12.92%

TNYA Profitability

Return on Equity

-113.74%

Return on Assets

-89.79%

Free Cashflow Yield

-66.85%

TNYA Investor Care

Shares Dilution (1Y)

110.18%

Diluted EPS (TTM)

-0.77

About Tenaya Therapeutics, Inc.

TNYA
Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, a gene therapy for myosin binding protein C3-associated hypertrophic cardiomyopathy; TN-301, a small molecule for heart failure with preserved ejection fraction; and TN-401, a gene therapy for plakophilin 2-associated arrhythmogenic right ventricular cardiomyopathy. It also develops an adeno-associated virus-based gene therapy designed to deliver the dwarf open reading frame gene in the heart for dilated cardiomyopathy; and reprogramming program for cardiac regeneration to replace heart cells lost in patients experiencing heart failure due to prior myocardial infarction. The company was incorporated in 2016 and is headquartered in South San Francisco, California.
 CEO
 WEBSITEtenayatherapeutics.com
 SECTORHealthcare
 INDUSTRYBiotechnology
 EMPLOYEES141

Tenaya Therapeutics, Inc. Frequently Asked Questions

TNYA is the stock ticker symbol of Tenaya Therapeutics, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of Tenaya Therapeutics, Inc. is 109.89 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check TNYA's fair value in chart for subscribers.

The fair value guage provides a quick view whether TNYA is over valued or under valued. Whether Tenaya Therapeutics, Inc. is cheap or expensive depends on the assumptions which impact Tenaya Therapeutics, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for TNYA.